10
|
Lopez-Olivo MA, Negrón JB, Zogala RJ, Carmona L, Criner K, Goel N, Gonzalez-Lopez L, Ingegnoli F, Leong A, March L, Shea B, Strand V, Tugwell P, Westrich-Robertson T, Zamora NV, Christensen R, Suarez-Almazor ME. Core Outcome Sets Specifically for Longterm Observational Studies: OMERACT Special Interest Group Update in Rheumatoid Arthritis. J Rheumatol 2019; 46:1164-1167. [PMID: 30824644 DOI: 10.3899/jrheum.181076] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 12/18/2018] [Indexed: 11/22/2022]
Abstract
OBJECTIVE This is an update from the Outcome Measures in Rheumatology (OMERACT) Core Outcomes in Longterm Observational Studies Special Interest Group with a focus on rheumatoid arthritis. METHODS Preliminary data and proposed next steps were outlined and discussed by participants. RESULTS Domains identified after initial steps (systematic review and qualitative research) were pain, physical functioning, participation (i.e., work, social), longterm symptoms, fertility/family planning, emotional well-being, coping, financial status, and adverse events including death. CONCLUSION The group agreed conceptually that short-term core outcomes could be different from longer term ones. Participants emphasized the importance of analyzing the need for core domains specifically for longterm longitudinal observational studies.
Collapse
Affiliation(s)
- Maria A Lopez-Olivo
- From the Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; Department of Medicine-Immunology, Allergy & Rheumatology, Baylor College of Medicine, Houston, Texas; Kezar Life Sciences, San Francisco; Healthy Motivation, Santa Barbara; Division of Immunology and Rheumatology, Stanford University, Palo Alto, California; Division of Rheumatology, Duke University School of Medicine, Durham, North Carolina; International Foundation for Autoimmune and Autoinflammatory Arthritis, St. Louis, Missouri, USA; Global Alliance for Musculoskeletal Health of the Bone and Joint Decade, Truro, Cornwall, UK; Instituto de Salud Musculoesqueletica, Madrid, Spain; Universidad de Guadalajara, Guadalajara, Mexico; Division of Clinical Rheumatology, G. Pini Hospital, Università degli Studi di Milano, Milan, Italy; Institute of Bone and Joint Research, Sydney Medical School, University of Sydney, Sydney, Australia; Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Instituto de Rehabilitacion Psicofisica, Buenos Aires, Argentina; Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; Department of Rheumatology, Odense University Hospital, Odense, Denmark.,M.A. Lopez-Olivo, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; J.B. Negrón, MSc, Instituto de Salud Musculoesqueletica; R.J. Zogala, MD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; L. Carmona, MD, PhD, Instituto de Salud Musculoesqueletica; K. Criner, MD, Department of Medicine-Immunology, Allergy & Rheumatology, Baylor College of Medicine; N. Goel, MD, PhD, Kezar Life Sciences, and Division of Rheumatology, Duke University School of Medicine; L. Gonzalez-Lopez, MD, MSc, PhD, Universidad de Guadalajara; F. Ingegnoli, MD, PhD, Division of Clinical Rheumatology, G. Pini Hospital, Università degli Studi di Milano; A. Leong, MBA, Healthy Motivation and the Global Alliance for Musculoskeletal Health of the Bone and Joint Decade; L. March, MBBS, MSc, PhD, FRACP, FAFPHM, Institute of Bone and Joint Research, Sydney Medical School, University of Sydney; B. Shea, PhD, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; V. Strand, MD, MACR, FACP, Biopharmaceutical Consultant, Portola Valley, California, USA; P. Tugwell, OC, MD, FRCPC, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; T. Westrich-Robertson, BS, International Foundation for Autoimmune and Autoinflammatory Arthritis; N.V. Zamora, MD, Instituto de Rehabilitacion Psicofisica; R. Christensen, MSc, PhD, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, and Department of Rheumatology, Odense University Hospital; M.E. Suarez-Almazor, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center
| | - José B Negrón
- From the Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; Department of Medicine-Immunology, Allergy & Rheumatology, Baylor College of Medicine, Houston, Texas; Kezar Life Sciences, San Francisco; Healthy Motivation, Santa Barbara; Division of Immunology and Rheumatology, Stanford University, Palo Alto, California; Division of Rheumatology, Duke University School of Medicine, Durham, North Carolina; International Foundation for Autoimmune and Autoinflammatory Arthritis, St. Louis, Missouri, USA; Global Alliance for Musculoskeletal Health of the Bone and Joint Decade, Truro, Cornwall, UK; Instituto de Salud Musculoesqueletica, Madrid, Spain; Universidad de Guadalajara, Guadalajara, Mexico; Division of Clinical Rheumatology, G. Pini Hospital, Università degli Studi di Milano, Milan, Italy; Institute of Bone and Joint Research, Sydney Medical School, University of Sydney, Sydney, Australia; Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Instituto de Rehabilitacion Psicofisica, Buenos Aires, Argentina; Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; Department of Rheumatology, Odense University Hospital, Odense, Denmark.,M.A. Lopez-Olivo, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; J.B. Negrón, MSc, Instituto de Salud Musculoesqueletica; R.J. Zogala, MD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; L. Carmona, MD, PhD, Instituto de Salud Musculoesqueletica; K. Criner, MD, Department of Medicine-Immunology, Allergy & Rheumatology, Baylor College of Medicine; N. Goel, MD, PhD, Kezar Life Sciences, and Division of Rheumatology, Duke University School of Medicine; L. Gonzalez-Lopez, MD, MSc, PhD, Universidad de Guadalajara; F. Ingegnoli, MD, PhD, Division of Clinical Rheumatology, G. Pini Hospital, Università degli Studi di Milano; A. Leong, MBA, Healthy Motivation and the Global Alliance for Musculoskeletal Health of the Bone and Joint Decade; L. March, MBBS, MSc, PhD, FRACP, FAFPHM, Institute of Bone and Joint Research, Sydney Medical School, University of Sydney; B. Shea, PhD, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; V. Strand, MD, MACR, FACP, Biopharmaceutical Consultant, Portola Valley, California, USA; P. Tugwell, OC, MD, FRCPC, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; T. Westrich-Robertson, BS, International Foundation for Autoimmune and Autoinflammatory Arthritis; N.V. Zamora, MD, Instituto de Rehabilitacion Psicofisica; R. Christensen, MSc, PhD, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, and Department of Rheumatology, Odense University Hospital; M.E. Suarez-Almazor, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center
| | - Richard J Zogala
- From the Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; Department of Medicine-Immunology, Allergy & Rheumatology, Baylor College of Medicine, Houston, Texas; Kezar Life Sciences, San Francisco; Healthy Motivation, Santa Barbara; Division of Immunology and Rheumatology, Stanford University, Palo Alto, California; Division of Rheumatology, Duke University School of Medicine, Durham, North Carolina; International Foundation for Autoimmune and Autoinflammatory Arthritis, St. Louis, Missouri, USA; Global Alliance for Musculoskeletal Health of the Bone and Joint Decade, Truro, Cornwall, UK; Instituto de Salud Musculoesqueletica, Madrid, Spain; Universidad de Guadalajara, Guadalajara, Mexico; Division of Clinical Rheumatology, G. Pini Hospital, Università degli Studi di Milano, Milan, Italy; Institute of Bone and Joint Research, Sydney Medical School, University of Sydney, Sydney, Australia; Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Instituto de Rehabilitacion Psicofisica, Buenos Aires, Argentina; Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; Department of Rheumatology, Odense University Hospital, Odense, Denmark.,M.A. Lopez-Olivo, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; J.B. Negrón, MSc, Instituto de Salud Musculoesqueletica; R.J. Zogala, MD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; L. Carmona, MD, PhD, Instituto de Salud Musculoesqueletica; K. Criner, MD, Department of Medicine-Immunology, Allergy & Rheumatology, Baylor College of Medicine; N. Goel, MD, PhD, Kezar Life Sciences, and Division of Rheumatology, Duke University School of Medicine; L. Gonzalez-Lopez, MD, MSc, PhD, Universidad de Guadalajara; F. Ingegnoli, MD, PhD, Division of Clinical Rheumatology, G. Pini Hospital, Università degli Studi di Milano; A. Leong, MBA, Healthy Motivation and the Global Alliance for Musculoskeletal Health of the Bone and Joint Decade; L. March, MBBS, MSc, PhD, FRACP, FAFPHM, Institute of Bone and Joint Research, Sydney Medical School, University of Sydney; B. Shea, PhD, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; V. Strand, MD, MACR, FACP, Biopharmaceutical Consultant, Portola Valley, California, USA; P. Tugwell, OC, MD, FRCPC, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; T. Westrich-Robertson, BS, International Foundation for Autoimmune and Autoinflammatory Arthritis; N.V. Zamora, MD, Instituto de Rehabilitacion Psicofisica; R. Christensen, MSc, PhD, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, and Department of Rheumatology, Odense University Hospital; M.E. Suarez-Almazor, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center
| | - Loreto Carmona
- From the Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; Department of Medicine-Immunology, Allergy & Rheumatology, Baylor College of Medicine, Houston, Texas; Kezar Life Sciences, San Francisco; Healthy Motivation, Santa Barbara; Division of Immunology and Rheumatology, Stanford University, Palo Alto, California; Division of Rheumatology, Duke University School of Medicine, Durham, North Carolina; International Foundation for Autoimmune and Autoinflammatory Arthritis, St. Louis, Missouri, USA; Global Alliance for Musculoskeletal Health of the Bone and Joint Decade, Truro, Cornwall, UK; Instituto de Salud Musculoesqueletica, Madrid, Spain; Universidad de Guadalajara, Guadalajara, Mexico; Division of Clinical Rheumatology, G. Pini Hospital, Università degli Studi di Milano, Milan, Italy; Institute of Bone and Joint Research, Sydney Medical School, University of Sydney, Sydney, Australia; Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Instituto de Rehabilitacion Psicofisica, Buenos Aires, Argentina; Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; Department of Rheumatology, Odense University Hospital, Odense, Denmark.,M.A. Lopez-Olivo, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; J.B. Negrón, MSc, Instituto de Salud Musculoesqueletica; R.J. Zogala, MD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; L. Carmona, MD, PhD, Instituto de Salud Musculoesqueletica; K. Criner, MD, Department of Medicine-Immunology, Allergy & Rheumatology, Baylor College of Medicine; N. Goel, MD, PhD, Kezar Life Sciences, and Division of Rheumatology, Duke University School of Medicine; L. Gonzalez-Lopez, MD, MSc, PhD, Universidad de Guadalajara; F. Ingegnoli, MD, PhD, Division of Clinical Rheumatology, G. Pini Hospital, Università degli Studi di Milano; A. Leong, MBA, Healthy Motivation and the Global Alliance for Musculoskeletal Health of the Bone and Joint Decade; L. March, MBBS, MSc, PhD, FRACP, FAFPHM, Institute of Bone and Joint Research, Sydney Medical School, University of Sydney; B. Shea, PhD, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; V. Strand, MD, MACR, FACP, Biopharmaceutical Consultant, Portola Valley, California, USA; P. Tugwell, OC, MD, FRCPC, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; T. Westrich-Robertson, BS, International Foundation for Autoimmune and Autoinflammatory Arthritis; N.V. Zamora, MD, Instituto de Rehabilitacion Psicofisica; R. Christensen, MSc, PhD, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, and Department of Rheumatology, Odense University Hospital; M.E. Suarez-Almazor, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center
| | - Karla Criner
- From the Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; Department of Medicine-Immunology, Allergy & Rheumatology, Baylor College of Medicine, Houston, Texas; Kezar Life Sciences, San Francisco; Healthy Motivation, Santa Barbara; Division of Immunology and Rheumatology, Stanford University, Palo Alto, California; Division of Rheumatology, Duke University School of Medicine, Durham, North Carolina; International Foundation for Autoimmune and Autoinflammatory Arthritis, St. Louis, Missouri, USA; Global Alliance for Musculoskeletal Health of the Bone and Joint Decade, Truro, Cornwall, UK; Instituto de Salud Musculoesqueletica, Madrid, Spain; Universidad de Guadalajara, Guadalajara, Mexico; Division of Clinical Rheumatology, G. Pini Hospital, Università degli Studi di Milano, Milan, Italy; Institute of Bone and Joint Research, Sydney Medical School, University of Sydney, Sydney, Australia; Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Instituto de Rehabilitacion Psicofisica, Buenos Aires, Argentina; Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; Department of Rheumatology, Odense University Hospital, Odense, Denmark.,M.A. Lopez-Olivo, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; J.B. Negrón, MSc, Instituto de Salud Musculoesqueletica; R.J. Zogala, MD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; L. Carmona, MD, PhD, Instituto de Salud Musculoesqueletica; K. Criner, MD, Department of Medicine-Immunology, Allergy & Rheumatology, Baylor College of Medicine; N. Goel, MD, PhD, Kezar Life Sciences, and Division of Rheumatology, Duke University School of Medicine; L. Gonzalez-Lopez, MD, MSc, PhD, Universidad de Guadalajara; F. Ingegnoli, MD, PhD, Division of Clinical Rheumatology, G. Pini Hospital, Università degli Studi di Milano; A. Leong, MBA, Healthy Motivation and the Global Alliance for Musculoskeletal Health of the Bone and Joint Decade; L. March, MBBS, MSc, PhD, FRACP, FAFPHM, Institute of Bone and Joint Research, Sydney Medical School, University of Sydney; B. Shea, PhD, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; V. Strand, MD, MACR, FACP, Biopharmaceutical Consultant, Portola Valley, California, USA; P. Tugwell, OC, MD, FRCPC, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; T. Westrich-Robertson, BS, International Foundation for Autoimmune and Autoinflammatory Arthritis; N.V. Zamora, MD, Instituto de Rehabilitacion Psicofisica; R. Christensen, MSc, PhD, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, and Department of Rheumatology, Odense University Hospital; M.E. Suarez-Almazor, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center
| | - Niti Goel
- From the Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; Department of Medicine-Immunology, Allergy & Rheumatology, Baylor College of Medicine, Houston, Texas; Kezar Life Sciences, San Francisco; Healthy Motivation, Santa Barbara; Division of Immunology and Rheumatology, Stanford University, Palo Alto, California; Division of Rheumatology, Duke University School of Medicine, Durham, North Carolina; International Foundation for Autoimmune and Autoinflammatory Arthritis, St. Louis, Missouri, USA; Global Alliance for Musculoskeletal Health of the Bone and Joint Decade, Truro, Cornwall, UK; Instituto de Salud Musculoesqueletica, Madrid, Spain; Universidad de Guadalajara, Guadalajara, Mexico; Division of Clinical Rheumatology, G. Pini Hospital, Università degli Studi di Milano, Milan, Italy; Institute of Bone and Joint Research, Sydney Medical School, University of Sydney, Sydney, Australia; Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Instituto de Rehabilitacion Psicofisica, Buenos Aires, Argentina; Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; Department of Rheumatology, Odense University Hospital, Odense, Denmark.,M.A. Lopez-Olivo, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; J.B. Negrón, MSc, Instituto de Salud Musculoesqueletica; R.J. Zogala, MD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; L. Carmona, MD, PhD, Instituto de Salud Musculoesqueletica; K. Criner, MD, Department of Medicine-Immunology, Allergy & Rheumatology, Baylor College of Medicine; N. Goel, MD, PhD, Kezar Life Sciences, and Division of Rheumatology, Duke University School of Medicine; L. Gonzalez-Lopez, MD, MSc, PhD, Universidad de Guadalajara; F. Ingegnoli, MD, PhD, Division of Clinical Rheumatology, G. Pini Hospital, Università degli Studi di Milano; A. Leong, MBA, Healthy Motivation and the Global Alliance for Musculoskeletal Health of the Bone and Joint Decade; L. March, MBBS, MSc, PhD, FRACP, FAFPHM, Institute of Bone and Joint Research, Sydney Medical School, University of Sydney; B. Shea, PhD, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; V. Strand, MD, MACR, FACP, Biopharmaceutical Consultant, Portola Valley, California, USA; P. Tugwell, OC, MD, FRCPC, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; T. Westrich-Robertson, BS, International Foundation for Autoimmune and Autoinflammatory Arthritis; N.V. Zamora, MD, Instituto de Rehabilitacion Psicofisica; R. Christensen, MSc, PhD, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, and Department of Rheumatology, Odense University Hospital; M.E. Suarez-Almazor, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center
| | - Laura Gonzalez-Lopez
- From the Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; Department of Medicine-Immunology, Allergy & Rheumatology, Baylor College of Medicine, Houston, Texas; Kezar Life Sciences, San Francisco; Healthy Motivation, Santa Barbara; Division of Immunology and Rheumatology, Stanford University, Palo Alto, California; Division of Rheumatology, Duke University School of Medicine, Durham, North Carolina; International Foundation for Autoimmune and Autoinflammatory Arthritis, St. Louis, Missouri, USA; Global Alliance for Musculoskeletal Health of the Bone and Joint Decade, Truro, Cornwall, UK; Instituto de Salud Musculoesqueletica, Madrid, Spain; Universidad de Guadalajara, Guadalajara, Mexico; Division of Clinical Rheumatology, G. Pini Hospital, Università degli Studi di Milano, Milan, Italy; Institute of Bone and Joint Research, Sydney Medical School, University of Sydney, Sydney, Australia; Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Instituto de Rehabilitacion Psicofisica, Buenos Aires, Argentina; Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; Department of Rheumatology, Odense University Hospital, Odense, Denmark.,M.A. Lopez-Olivo, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; J.B. Negrón, MSc, Instituto de Salud Musculoesqueletica; R.J. Zogala, MD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; L. Carmona, MD, PhD, Instituto de Salud Musculoesqueletica; K. Criner, MD, Department of Medicine-Immunology, Allergy & Rheumatology, Baylor College of Medicine; N. Goel, MD, PhD, Kezar Life Sciences, and Division of Rheumatology, Duke University School of Medicine; L. Gonzalez-Lopez, MD, MSc, PhD, Universidad de Guadalajara; F. Ingegnoli, MD, PhD, Division of Clinical Rheumatology, G. Pini Hospital, Università degli Studi di Milano; A. Leong, MBA, Healthy Motivation and the Global Alliance for Musculoskeletal Health of the Bone and Joint Decade; L. March, MBBS, MSc, PhD, FRACP, FAFPHM, Institute of Bone and Joint Research, Sydney Medical School, University of Sydney; B. Shea, PhD, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; V. Strand, MD, MACR, FACP, Biopharmaceutical Consultant, Portola Valley, California, USA; P. Tugwell, OC, MD, FRCPC, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; T. Westrich-Robertson, BS, International Foundation for Autoimmune and Autoinflammatory Arthritis; N.V. Zamora, MD, Instituto de Rehabilitacion Psicofisica; R. Christensen, MSc, PhD, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, and Department of Rheumatology, Odense University Hospital; M.E. Suarez-Almazor, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center
| | - Francesca Ingegnoli
- From the Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; Department of Medicine-Immunology, Allergy & Rheumatology, Baylor College of Medicine, Houston, Texas; Kezar Life Sciences, San Francisco; Healthy Motivation, Santa Barbara; Division of Immunology and Rheumatology, Stanford University, Palo Alto, California; Division of Rheumatology, Duke University School of Medicine, Durham, North Carolina; International Foundation for Autoimmune and Autoinflammatory Arthritis, St. Louis, Missouri, USA; Global Alliance for Musculoskeletal Health of the Bone and Joint Decade, Truro, Cornwall, UK; Instituto de Salud Musculoesqueletica, Madrid, Spain; Universidad de Guadalajara, Guadalajara, Mexico; Division of Clinical Rheumatology, G. Pini Hospital, Università degli Studi di Milano, Milan, Italy; Institute of Bone and Joint Research, Sydney Medical School, University of Sydney, Sydney, Australia; Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Instituto de Rehabilitacion Psicofisica, Buenos Aires, Argentina; Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; Department of Rheumatology, Odense University Hospital, Odense, Denmark.,M.A. Lopez-Olivo, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; J.B. Negrón, MSc, Instituto de Salud Musculoesqueletica; R.J. Zogala, MD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; L. Carmona, MD, PhD, Instituto de Salud Musculoesqueletica; K. Criner, MD, Department of Medicine-Immunology, Allergy & Rheumatology, Baylor College of Medicine; N. Goel, MD, PhD, Kezar Life Sciences, and Division of Rheumatology, Duke University School of Medicine; L. Gonzalez-Lopez, MD, MSc, PhD, Universidad de Guadalajara; F. Ingegnoli, MD, PhD, Division of Clinical Rheumatology, G. Pini Hospital, Università degli Studi di Milano; A. Leong, MBA, Healthy Motivation and the Global Alliance for Musculoskeletal Health of the Bone and Joint Decade; L. March, MBBS, MSc, PhD, FRACP, FAFPHM, Institute of Bone and Joint Research, Sydney Medical School, University of Sydney; B. Shea, PhD, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; V. Strand, MD, MACR, FACP, Biopharmaceutical Consultant, Portola Valley, California, USA; P. Tugwell, OC, MD, FRCPC, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; T. Westrich-Robertson, BS, International Foundation for Autoimmune and Autoinflammatory Arthritis; N.V. Zamora, MD, Instituto de Rehabilitacion Psicofisica; R. Christensen, MSc, PhD, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, and Department of Rheumatology, Odense University Hospital; M.E. Suarez-Almazor, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center
| | - Amye Leong
- From the Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; Department of Medicine-Immunology, Allergy & Rheumatology, Baylor College of Medicine, Houston, Texas; Kezar Life Sciences, San Francisco; Healthy Motivation, Santa Barbara; Division of Immunology and Rheumatology, Stanford University, Palo Alto, California; Division of Rheumatology, Duke University School of Medicine, Durham, North Carolina; International Foundation for Autoimmune and Autoinflammatory Arthritis, St. Louis, Missouri, USA; Global Alliance for Musculoskeletal Health of the Bone and Joint Decade, Truro, Cornwall, UK; Instituto de Salud Musculoesqueletica, Madrid, Spain; Universidad de Guadalajara, Guadalajara, Mexico; Division of Clinical Rheumatology, G. Pini Hospital, Università degli Studi di Milano, Milan, Italy; Institute of Bone and Joint Research, Sydney Medical School, University of Sydney, Sydney, Australia; Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Instituto de Rehabilitacion Psicofisica, Buenos Aires, Argentina; Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; Department of Rheumatology, Odense University Hospital, Odense, Denmark.,M.A. Lopez-Olivo, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; J.B. Negrón, MSc, Instituto de Salud Musculoesqueletica; R.J. Zogala, MD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; L. Carmona, MD, PhD, Instituto de Salud Musculoesqueletica; K. Criner, MD, Department of Medicine-Immunology, Allergy & Rheumatology, Baylor College of Medicine; N. Goel, MD, PhD, Kezar Life Sciences, and Division of Rheumatology, Duke University School of Medicine; L. Gonzalez-Lopez, MD, MSc, PhD, Universidad de Guadalajara; F. Ingegnoli, MD, PhD, Division of Clinical Rheumatology, G. Pini Hospital, Università degli Studi di Milano; A. Leong, MBA, Healthy Motivation and the Global Alliance for Musculoskeletal Health of the Bone and Joint Decade; L. March, MBBS, MSc, PhD, FRACP, FAFPHM, Institute of Bone and Joint Research, Sydney Medical School, University of Sydney; B. Shea, PhD, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; V. Strand, MD, MACR, FACP, Biopharmaceutical Consultant, Portola Valley, California, USA; P. Tugwell, OC, MD, FRCPC, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; T. Westrich-Robertson, BS, International Foundation for Autoimmune and Autoinflammatory Arthritis; N.V. Zamora, MD, Instituto de Rehabilitacion Psicofisica; R. Christensen, MSc, PhD, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, and Department of Rheumatology, Odense University Hospital; M.E. Suarez-Almazor, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center
| | - Lyn March
- From the Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; Department of Medicine-Immunology, Allergy & Rheumatology, Baylor College of Medicine, Houston, Texas; Kezar Life Sciences, San Francisco; Healthy Motivation, Santa Barbara; Division of Immunology and Rheumatology, Stanford University, Palo Alto, California; Division of Rheumatology, Duke University School of Medicine, Durham, North Carolina; International Foundation for Autoimmune and Autoinflammatory Arthritis, St. Louis, Missouri, USA; Global Alliance for Musculoskeletal Health of the Bone and Joint Decade, Truro, Cornwall, UK; Instituto de Salud Musculoesqueletica, Madrid, Spain; Universidad de Guadalajara, Guadalajara, Mexico; Division of Clinical Rheumatology, G. Pini Hospital, Università degli Studi di Milano, Milan, Italy; Institute of Bone and Joint Research, Sydney Medical School, University of Sydney, Sydney, Australia; Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Instituto de Rehabilitacion Psicofisica, Buenos Aires, Argentina; Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; Department of Rheumatology, Odense University Hospital, Odense, Denmark.,M.A. Lopez-Olivo, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; J.B. Negrón, MSc, Instituto de Salud Musculoesqueletica; R.J. Zogala, MD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; L. Carmona, MD, PhD, Instituto de Salud Musculoesqueletica; K. Criner, MD, Department of Medicine-Immunology, Allergy & Rheumatology, Baylor College of Medicine; N. Goel, MD, PhD, Kezar Life Sciences, and Division of Rheumatology, Duke University School of Medicine; L. Gonzalez-Lopez, MD, MSc, PhD, Universidad de Guadalajara; F. Ingegnoli, MD, PhD, Division of Clinical Rheumatology, G. Pini Hospital, Università degli Studi di Milano; A. Leong, MBA, Healthy Motivation and the Global Alliance for Musculoskeletal Health of the Bone and Joint Decade; L. March, MBBS, MSc, PhD, FRACP, FAFPHM, Institute of Bone and Joint Research, Sydney Medical School, University of Sydney; B. Shea, PhD, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; V. Strand, MD, MACR, FACP, Biopharmaceutical Consultant, Portola Valley, California, USA; P. Tugwell, OC, MD, FRCPC, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; T. Westrich-Robertson, BS, International Foundation for Autoimmune and Autoinflammatory Arthritis; N.V. Zamora, MD, Instituto de Rehabilitacion Psicofisica; R. Christensen, MSc, PhD, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, and Department of Rheumatology, Odense University Hospital; M.E. Suarez-Almazor, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center
| | - Beverly Shea
- From the Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; Department of Medicine-Immunology, Allergy & Rheumatology, Baylor College of Medicine, Houston, Texas; Kezar Life Sciences, San Francisco; Healthy Motivation, Santa Barbara; Division of Immunology and Rheumatology, Stanford University, Palo Alto, California; Division of Rheumatology, Duke University School of Medicine, Durham, North Carolina; International Foundation for Autoimmune and Autoinflammatory Arthritis, St. Louis, Missouri, USA; Global Alliance for Musculoskeletal Health of the Bone and Joint Decade, Truro, Cornwall, UK; Instituto de Salud Musculoesqueletica, Madrid, Spain; Universidad de Guadalajara, Guadalajara, Mexico; Division of Clinical Rheumatology, G. Pini Hospital, Università degli Studi di Milano, Milan, Italy; Institute of Bone and Joint Research, Sydney Medical School, University of Sydney, Sydney, Australia; Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Instituto de Rehabilitacion Psicofisica, Buenos Aires, Argentina; Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; Department of Rheumatology, Odense University Hospital, Odense, Denmark.,M.A. Lopez-Olivo, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; J.B. Negrón, MSc, Instituto de Salud Musculoesqueletica; R.J. Zogala, MD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; L. Carmona, MD, PhD, Instituto de Salud Musculoesqueletica; K. Criner, MD, Department of Medicine-Immunology, Allergy & Rheumatology, Baylor College of Medicine; N. Goel, MD, PhD, Kezar Life Sciences, and Division of Rheumatology, Duke University School of Medicine; L. Gonzalez-Lopez, MD, MSc, PhD, Universidad de Guadalajara; F. Ingegnoli, MD, PhD, Division of Clinical Rheumatology, G. Pini Hospital, Università degli Studi di Milano; A. Leong, MBA, Healthy Motivation and the Global Alliance for Musculoskeletal Health of the Bone and Joint Decade; L. March, MBBS, MSc, PhD, FRACP, FAFPHM, Institute of Bone and Joint Research, Sydney Medical School, University of Sydney; B. Shea, PhD, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; V. Strand, MD, MACR, FACP, Biopharmaceutical Consultant, Portola Valley, California, USA; P. Tugwell, OC, MD, FRCPC, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; T. Westrich-Robertson, BS, International Foundation for Autoimmune and Autoinflammatory Arthritis; N.V. Zamora, MD, Instituto de Rehabilitacion Psicofisica; R. Christensen, MSc, PhD, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, and Department of Rheumatology, Odense University Hospital; M.E. Suarez-Almazor, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center
| | - Vibeke Strand
- From the Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; Department of Medicine-Immunology, Allergy & Rheumatology, Baylor College of Medicine, Houston, Texas; Kezar Life Sciences, San Francisco; Healthy Motivation, Santa Barbara; Division of Immunology and Rheumatology, Stanford University, Palo Alto, California; Division of Rheumatology, Duke University School of Medicine, Durham, North Carolina; International Foundation for Autoimmune and Autoinflammatory Arthritis, St. Louis, Missouri, USA; Global Alliance for Musculoskeletal Health of the Bone and Joint Decade, Truro, Cornwall, UK; Instituto de Salud Musculoesqueletica, Madrid, Spain; Universidad de Guadalajara, Guadalajara, Mexico; Division of Clinical Rheumatology, G. Pini Hospital, Università degli Studi di Milano, Milan, Italy; Institute of Bone and Joint Research, Sydney Medical School, University of Sydney, Sydney, Australia; Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Instituto de Rehabilitacion Psicofisica, Buenos Aires, Argentina; Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; Department of Rheumatology, Odense University Hospital, Odense, Denmark.,M.A. Lopez-Olivo, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; J.B. Negrón, MSc, Instituto de Salud Musculoesqueletica; R.J. Zogala, MD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; L. Carmona, MD, PhD, Instituto de Salud Musculoesqueletica; K. Criner, MD, Department of Medicine-Immunology, Allergy & Rheumatology, Baylor College of Medicine; N. Goel, MD, PhD, Kezar Life Sciences, and Division of Rheumatology, Duke University School of Medicine; L. Gonzalez-Lopez, MD, MSc, PhD, Universidad de Guadalajara; F. Ingegnoli, MD, PhD, Division of Clinical Rheumatology, G. Pini Hospital, Università degli Studi di Milano; A. Leong, MBA, Healthy Motivation and the Global Alliance for Musculoskeletal Health of the Bone and Joint Decade; L. March, MBBS, MSc, PhD, FRACP, FAFPHM, Institute of Bone and Joint Research, Sydney Medical School, University of Sydney; B. Shea, PhD, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; V. Strand, MD, MACR, FACP, Biopharmaceutical Consultant, Portola Valley, California, USA; P. Tugwell, OC, MD, FRCPC, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; T. Westrich-Robertson, BS, International Foundation for Autoimmune and Autoinflammatory Arthritis; N.V. Zamora, MD, Instituto de Rehabilitacion Psicofisica; R. Christensen, MSc, PhD, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, and Department of Rheumatology, Odense University Hospital; M.E. Suarez-Almazor, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center
| | - Peter Tugwell
- From the Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; Department of Medicine-Immunology, Allergy & Rheumatology, Baylor College of Medicine, Houston, Texas; Kezar Life Sciences, San Francisco; Healthy Motivation, Santa Barbara; Division of Immunology and Rheumatology, Stanford University, Palo Alto, California; Division of Rheumatology, Duke University School of Medicine, Durham, North Carolina; International Foundation for Autoimmune and Autoinflammatory Arthritis, St. Louis, Missouri, USA; Global Alliance for Musculoskeletal Health of the Bone and Joint Decade, Truro, Cornwall, UK; Instituto de Salud Musculoesqueletica, Madrid, Spain; Universidad de Guadalajara, Guadalajara, Mexico; Division of Clinical Rheumatology, G. Pini Hospital, Università degli Studi di Milano, Milan, Italy; Institute of Bone and Joint Research, Sydney Medical School, University of Sydney, Sydney, Australia; Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Instituto de Rehabilitacion Psicofisica, Buenos Aires, Argentina; Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; Department of Rheumatology, Odense University Hospital, Odense, Denmark.,M.A. Lopez-Olivo, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; J.B. Negrón, MSc, Instituto de Salud Musculoesqueletica; R.J. Zogala, MD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; L. Carmona, MD, PhD, Instituto de Salud Musculoesqueletica; K. Criner, MD, Department of Medicine-Immunology, Allergy & Rheumatology, Baylor College of Medicine; N. Goel, MD, PhD, Kezar Life Sciences, and Division of Rheumatology, Duke University School of Medicine; L. Gonzalez-Lopez, MD, MSc, PhD, Universidad de Guadalajara; F. Ingegnoli, MD, PhD, Division of Clinical Rheumatology, G. Pini Hospital, Università degli Studi di Milano; A. Leong, MBA, Healthy Motivation and the Global Alliance for Musculoskeletal Health of the Bone and Joint Decade; L. March, MBBS, MSc, PhD, FRACP, FAFPHM, Institute of Bone and Joint Research, Sydney Medical School, University of Sydney; B. Shea, PhD, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; V. Strand, MD, MACR, FACP, Biopharmaceutical Consultant, Portola Valley, California, USA; P. Tugwell, OC, MD, FRCPC, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; T. Westrich-Robertson, BS, International Foundation for Autoimmune and Autoinflammatory Arthritis; N.V. Zamora, MD, Instituto de Rehabilitacion Psicofisica; R. Christensen, MSc, PhD, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, and Department of Rheumatology, Odense University Hospital; M.E. Suarez-Almazor, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center
| | - Tiffany Westrich-Robertson
- From the Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; Department of Medicine-Immunology, Allergy & Rheumatology, Baylor College of Medicine, Houston, Texas; Kezar Life Sciences, San Francisco; Healthy Motivation, Santa Barbara; Division of Immunology and Rheumatology, Stanford University, Palo Alto, California; Division of Rheumatology, Duke University School of Medicine, Durham, North Carolina; International Foundation for Autoimmune and Autoinflammatory Arthritis, St. Louis, Missouri, USA; Global Alliance for Musculoskeletal Health of the Bone and Joint Decade, Truro, Cornwall, UK; Instituto de Salud Musculoesqueletica, Madrid, Spain; Universidad de Guadalajara, Guadalajara, Mexico; Division of Clinical Rheumatology, G. Pini Hospital, Università degli Studi di Milano, Milan, Italy; Institute of Bone and Joint Research, Sydney Medical School, University of Sydney, Sydney, Australia; Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Instituto de Rehabilitacion Psicofisica, Buenos Aires, Argentina; Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; Department of Rheumatology, Odense University Hospital, Odense, Denmark.,M.A. Lopez-Olivo, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; J.B. Negrón, MSc, Instituto de Salud Musculoesqueletica; R.J. Zogala, MD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; L. Carmona, MD, PhD, Instituto de Salud Musculoesqueletica; K. Criner, MD, Department of Medicine-Immunology, Allergy & Rheumatology, Baylor College of Medicine; N. Goel, MD, PhD, Kezar Life Sciences, and Division of Rheumatology, Duke University School of Medicine; L. Gonzalez-Lopez, MD, MSc, PhD, Universidad de Guadalajara; F. Ingegnoli, MD, PhD, Division of Clinical Rheumatology, G. Pini Hospital, Università degli Studi di Milano; A. Leong, MBA, Healthy Motivation and the Global Alliance for Musculoskeletal Health of the Bone and Joint Decade; L. March, MBBS, MSc, PhD, FRACP, FAFPHM, Institute of Bone and Joint Research, Sydney Medical School, University of Sydney; B. Shea, PhD, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; V. Strand, MD, MACR, FACP, Biopharmaceutical Consultant, Portola Valley, California, USA; P. Tugwell, OC, MD, FRCPC, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; T. Westrich-Robertson, BS, International Foundation for Autoimmune and Autoinflammatory Arthritis; N.V. Zamora, MD, Instituto de Rehabilitacion Psicofisica; R. Christensen, MSc, PhD, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, and Department of Rheumatology, Odense University Hospital; M.E. Suarez-Almazor, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center
| | - Natalia V Zamora
- From the Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; Department of Medicine-Immunology, Allergy & Rheumatology, Baylor College of Medicine, Houston, Texas; Kezar Life Sciences, San Francisco; Healthy Motivation, Santa Barbara; Division of Immunology and Rheumatology, Stanford University, Palo Alto, California; Division of Rheumatology, Duke University School of Medicine, Durham, North Carolina; International Foundation for Autoimmune and Autoinflammatory Arthritis, St. Louis, Missouri, USA; Global Alliance for Musculoskeletal Health of the Bone and Joint Decade, Truro, Cornwall, UK; Instituto de Salud Musculoesqueletica, Madrid, Spain; Universidad de Guadalajara, Guadalajara, Mexico; Division of Clinical Rheumatology, G. Pini Hospital, Università degli Studi di Milano, Milan, Italy; Institute of Bone and Joint Research, Sydney Medical School, University of Sydney, Sydney, Australia; Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Instituto de Rehabilitacion Psicofisica, Buenos Aires, Argentina; Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; Department of Rheumatology, Odense University Hospital, Odense, Denmark.,M.A. Lopez-Olivo, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; J.B. Negrón, MSc, Instituto de Salud Musculoesqueletica; R.J. Zogala, MD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; L. Carmona, MD, PhD, Instituto de Salud Musculoesqueletica; K. Criner, MD, Department of Medicine-Immunology, Allergy & Rheumatology, Baylor College of Medicine; N. Goel, MD, PhD, Kezar Life Sciences, and Division of Rheumatology, Duke University School of Medicine; L. Gonzalez-Lopez, MD, MSc, PhD, Universidad de Guadalajara; F. Ingegnoli, MD, PhD, Division of Clinical Rheumatology, G. Pini Hospital, Università degli Studi di Milano; A. Leong, MBA, Healthy Motivation and the Global Alliance for Musculoskeletal Health of the Bone and Joint Decade; L. March, MBBS, MSc, PhD, FRACP, FAFPHM, Institute of Bone and Joint Research, Sydney Medical School, University of Sydney; B. Shea, PhD, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; V. Strand, MD, MACR, FACP, Biopharmaceutical Consultant, Portola Valley, California, USA; P. Tugwell, OC, MD, FRCPC, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; T. Westrich-Robertson, BS, International Foundation for Autoimmune and Autoinflammatory Arthritis; N.V. Zamora, MD, Instituto de Rehabilitacion Psicofisica; R. Christensen, MSc, PhD, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, and Department of Rheumatology, Odense University Hospital; M.E. Suarez-Almazor, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center
| | - Robin Christensen
- From the Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; Department of Medicine-Immunology, Allergy & Rheumatology, Baylor College of Medicine, Houston, Texas; Kezar Life Sciences, San Francisco; Healthy Motivation, Santa Barbara; Division of Immunology and Rheumatology, Stanford University, Palo Alto, California; Division of Rheumatology, Duke University School of Medicine, Durham, North Carolina; International Foundation for Autoimmune and Autoinflammatory Arthritis, St. Louis, Missouri, USA; Global Alliance for Musculoskeletal Health of the Bone and Joint Decade, Truro, Cornwall, UK; Instituto de Salud Musculoesqueletica, Madrid, Spain; Universidad de Guadalajara, Guadalajara, Mexico; Division of Clinical Rheumatology, G. Pini Hospital, Università degli Studi di Milano, Milan, Italy; Institute of Bone and Joint Research, Sydney Medical School, University of Sydney, Sydney, Australia; Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Instituto de Rehabilitacion Psicofisica, Buenos Aires, Argentina; Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; Department of Rheumatology, Odense University Hospital, Odense, Denmark.,M.A. Lopez-Olivo, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; J.B. Negrón, MSc, Instituto de Salud Musculoesqueletica; R.J. Zogala, MD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; L. Carmona, MD, PhD, Instituto de Salud Musculoesqueletica; K. Criner, MD, Department of Medicine-Immunology, Allergy & Rheumatology, Baylor College of Medicine; N. Goel, MD, PhD, Kezar Life Sciences, and Division of Rheumatology, Duke University School of Medicine; L. Gonzalez-Lopez, MD, MSc, PhD, Universidad de Guadalajara; F. Ingegnoli, MD, PhD, Division of Clinical Rheumatology, G. Pini Hospital, Università degli Studi di Milano; A. Leong, MBA, Healthy Motivation and the Global Alliance for Musculoskeletal Health of the Bone and Joint Decade; L. March, MBBS, MSc, PhD, FRACP, FAFPHM, Institute of Bone and Joint Research, Sydney Medical School, University of Sydney; B. Shea, PhD, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; V. Strand, MD, MACR, FACP, Biopharmaceutical Consultant, Portola Valley, California, USA; P. Tugwell, OC, MD, FRCPC, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; T. Westrich-Robertson, BS, International Foundation for Autoimmune and Autoinflammatory Arthritis; N.V. Zamora, MD, Instituto de Rehabilitacion Psicofisica; R. Christensen, MSc, PhD, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, and Department of Rheumatology, Odense University Hospital; M.E. Suarez-Almazor, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center
| | - Maria E Suarez-Almazor
- From the Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; Department of Medicine-Immunology, Allergy & Rheumatology, Baylor College of Medicine, Houston, Texas; Kezar Life Sciences, San Francisco; Healthy Motivation, Santa Barbara; Division of Immunology and Rheumatology, Stanford University, Palo Alto, California; Division of Rheumatology, Duke University School of Medicine, Durham, North Carolina; International Foundation for Autoimmune and Autoinflammatory Arthritis, St. Louis, Missouri, USA; Global Alliance for Musculoskeletal Health of the Bone and Joint Decade, Truro, Cornwall, UK; Instituto de Salud Musculoesqueletica, Madrid, Spain; Universidad de Guadalajara, Guadalajara, Mexico; Division of Clinical Rheumatology, G. Pini Hospital, Università degli Studi di Milano, Milan, Italy; Institute of Bone and Joint Research, Sydney Medical School, University of Sydney, Sydney, Australia; Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Instituto de Rehabilitacion Psicofisica, Buenos Aires, Argentina; Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; Department of Rheumatology, Odense University Hospital, Odense, Denmark. .,M.A. Lopez-Olivo, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; J.B. Negrón, MSc, Instituto de Salud Musculoesqueletica; R.J. Zogala, MD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; L. Carmona, MD, PhD, Instituto de Salud Musculoesqueletica; K. Criner, MD, Department of Medicine-Immunology, Allergy & Rheumatology, Baylor College of Medicine; N. Goel, MD, PhD, Kezar Life Sciences, and Division of Rheumatology, Duke University School of Medicine; L. Gonzalez-Lopez, MD, MSc, PhD, Universidad de Guadalajara; F. Ingegnoli, MD, PhD, Division of Clinical Rheumatology, G. Pini Hospital, Università degli Studi di Milano; A. Leong, MBA, Healthy Motivation and the Global Alliance for Musculoskeletal Health of the Bone and Joint Decade; L. March, MBBS, MSc, PhD, FRACP, FAFPHM, Institute of Bone and Joint Research, Sydney Medical School, University of Sydney; B. Shea, PhD, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; V. Strand, MD, MACR, FACP, Biopharmaceutical Consultant, Portola Valley, California, USA; P. Tugwell, OC, MD, FRCPC, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; T. Westrich-Robertson, BS, International Foundation for Autoimmune and Autoinflammatory Arthritis; N.V. Zamora, MD, Instituto de Rehabilitacion Psicofisica; R. Christensen, MSc, PhD, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, and Department of Rheumatology, Odense University Hospital; M.E. Suarez-Almazor, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center.
| |
Collapse
|